Tag: Nimodipine

According to the American Heart Association/American Stroke Association (AHA/ASA), nimodipine is a key medication to improve neurological outcomes following aneurysmal subarachnoid hemorrhage. When considering **what medication is given after aneurysm** treatment, the approach is highly dependent on whether the aneurysm was ruptured and its location. This article provides a general overview of the different medications and their purposes in post-aneurysm care.

About 30,000 people in the United States suffer a brain aneurysm rupture each year, which is one every 18 minutes. When this critical event occurs, understanding **what is the drug of choice for a brain aneurysm** becomes essential for managing life-threatening complications.

According to research, nimodipine, known by the brand name Nimotop, is the only established pharmacological treatment proven to improve outcomes for patients suffering from subarachnoid hemorrhage (SAH). This medication achieves its effect by interfering with specific cellular processes in the brain to reduce secondary injury.